Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Total Assignments:
4
|
|
Patent #:
|
|
Issue Dt:
|
02/19/2019
|
Application #:
|
14357512
|
Filing Dt:
|
05/09/2014
|
|
Publication #:
|
|
Pub Dt:
|
10/30/2014
| | | | |
|
Inventors:
|
Philip Greenberg, Sebastian Ochsenreither
|
|
Title:
|
CYCLIN A1-TARGETED T-CELL IMMUNOTHERAPY FOR CANCER
|
|
|
Assignment:
1
|
|
|
|
|
|
|
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| 1100 FAIRVIEW AVENUE NORTH |
| J5-110 |
| SEATTLE, WASHINGTON 98109 |
|
|
|
|
| STEPHEN J. ROSENMAN, PH.D. |
| SEED IP LAW GROUP PLLC |
| 701 FIFTH AVENUE, SUITE 5400 |
| SEATTLE, WA 98104 |
|
|
|
Assignment:
2
|
|
|
|
|
|
|
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
|
|
|
| NIH DIVISION OF EXTRAMURAL INVENTIONS AND TECHNOLOGY RESOURCES (DEITR) |
| 6705 ROCKLEDGE DRIVE, SUITE 310, MSC 7980 |
| BETHESDA, MARYLAND 20892-7980 |
|
|
|
|
| DIRECTOR, DEITR |
| NIH, 6705 ROCKLEDGE DRIVE, SUITE 310 |
| MSC 7980 |
| BETHESDA, MD 20892-7980 |
|
|
|
Assignment:
3
|
|
|
|
|
|
|
MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
Newly Merged Entity's New Name:
|
|
|
|
| 1100 FAIRVIEW AVENUE N. |
| SEATTLE, WASHINGTON 98109 |
|
|
|
|
| JOHN A. MORGAN |
| SEED IP LAW GROUP LLP |
| 701 FIFTH AVENUE, SUITE 5400 |
| SEATTLE, WA 98104 |
|
|
|
Assignment:
4
|
|
|
|
|
|
|
MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
|
|
|
|
|
|
Newly Merged Entity's New Name:
|
|
|
|
| 1100 FAIRVIEW AVENUE N. |
| SEATTLE, WASHINGTON 98109 |
|
|
|
|
| JOHN A. MORGAN |
| SEED IP LAW GROUP LLP |
| 701 FIFTH AVENUE, SUITE 5400 |
| SEATTLE, WA 98104 |
|
|
Search Results as of:
05/13/2024 08:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
